{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T15:10:02Z","timestamp":1742569802898,"version":"3.40.2"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T00:00:00Z","timestamp":1742515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T00:00:00Z","timestamp":1742515200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Dystrophic epidermolysis bullosa (DEB) is a rare group of genetic skin-fragility conditions resulting in blisters and erosions of the skin and mucosa, evolving into dystrophic and retractile scars. This study objective is to describe the genital involvement in women with DEB and their gynaeco-obstetrical life.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>In this prospective two-centre study, data from women with DEB who were older than 18\u00a0years was gathered into a questionnaire by the dermatologist and\/or gynaecologist investigators. This data was collected from patients\u2019 medical records with regard to menstrual cycles, contraception methods, the obstetrical history, screening for gynaecological cancers and sexually transmitted diseases, and the sexual life. Vulvar examinations were carried out as part of the usual follow-up. In total, 27 women (median age 35\u00a0years; range 19 to 72) were recruited and their data included in the study between January and December 2021. The gynaecological follow-up was reported as regular for 14 of the 27 (52%) women; 16\/27 (59%) mentioned menstruating; 13\/24 (51%) had already had at least one contraceptive treatment; 17\/27 (63%) declared they had sexual intercourse at least once, most often with difficulties; and 10\/27 (37%) had full-term pregnancies, with 1 to 4 children per woman (i.e., 21 deliveries: 8 caesarean sections and 13 vaginal deliveries). Eleven of the 21 women who had a vulvar examination during follow-up had a lesion at the time of the exam. According to French recommendations, the rate of screening for sexually transmitted diseases (STDs), cervical cancer, and breast cancer was 18% (all over 25\u00a0years old), 70%, and 100%, respectively.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>As for all patients, women with DEB need gynaecological follow-up during their life. A sexology consultation is also highly recommended to help with the psychosexual aspect of DEB and to inform patients about specific preventive measures to avoid lesions during the sexual act, for contraception and for STDs screening. Pregnancies and deliveries are possible even in women with severe disease, most often without major complications.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13023-024-03434-0","type":"journal-article","created":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T14:28:12Z","timestamp":1742567292000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Gynaeco-obstetrical follow-up of patients with dystrophic epidermolysis bullosa, a prospective study"],"prefix":"10.1186","volume":"20","author":[{"given":"M.","family":"Fournier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Bourrat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Rapp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Vexiau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Trastour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6063-5409","authenticated-orcid":false,"given":"C.","family":"Chiaverini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,21]]},"reference":[{"key":"3434_CR1","unstructured":"Haute Autorit\u00e9 de Sant\u00e9 - IST_la HAS recommande un d\u00e9pistage syst\u00e9matique de l\u2019infection \u00e0 Chlamydia trachomatis chez les jeunes femmes.pdf. https:\/\/www.has-sante.fr\/jcms\/c_2879454\/fr\/ist-la-has-recommande-un-depistage-systematique-de-l-infection-a-chlamydia-trachomatis-chez-les-jeunes-femmes"},{"key":"3434_CR2","unstructured":"Haute Autorit\u00e9 de Sant\u00e9 - D\u00e9pistage du cancer du col de l\u2019ut\u00e9rus _ le test HPV-HR recommand\u00e9 chez les femmes de plus de 30 ans.pdf. https:\/\/www.has-sante.fr\/jcms\/p_3192618\/fr\/depistage-du-cancer-du-col-de-l-uterus-le-test-hpv-hr-recommande-chez-les-femmes-de-plus-de-30-ans"},{"key":"3434_CR3","unstructured":"Haute Autorit\u00e9 de Sant\u00e9 HAS. D\u00e9pistage et pr\u00e9vention du cancer du sein [Internet]. Saint-Denis La Plaine; 2014. https:\/\/www.has-sante.fr\/jcms\/c_2024559\/fr\/depistage-et-prevention-du-cancer-du-sein"},{"issue":"1","key":"3434_CR4","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13023-020-01640-0","volume":"16","author":"A King","year":"2021","unstructured":"King A, Hanley H, Popenhagen M, Perez F, Thompson K, Purvis D, et al. Supporting sexuality for people living with epidermolysis bullosa: clinical practice guidelines. Orphanet J Rare Dis. 2021;16(1):9.","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"3434_CR5","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1111\/bjd.20809","volume":"186","author":"DT Greenblatt","year":"2022","unstructured":"Greenblatt DT, Pillay E, Snelson K, Saad R, Torres Pradilla M, Widhiati S, et al. Recommendations on pregnancy, childbirth and aftercare in epidermolysis bullosa: a consensus-based guideline. Br J Dermatol. 2022;186(4):620\u201332.","journal-title":"Br J Dermatol"},{"issue":"3","key":"3434_CR6","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1258\/om.2010.100009","volume":"3","author":"LA Bolt","year":"2010","unstructured":"Bolt LA, O\u2019Sullivan G, Rajasingham D, Shennan A. A review of the obstetric management of patients with epidermolysis bullosa. Obstet Med. 2010;3(3):101\u20135.","journal-title":"Obstet Med"},{"issue":"1","key":"3434_CR7","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.ijwd.2017.02.002","volume":"3","author":"LRA Intong","year":"2017","unstructured":"Intong LRA, Choi SD, Shipman A, Kho YC, Hwang SJE, Rhodes LM, et al. Retrospective evidence on outcomes and experiences of pregnancy and childbirth in epidermolysis bullosa in Australia and New Zealand. Int J Womens Dermatol. 2017;3(1):S1-5.","journal-title":"Int J Womens Dermatol"},{"issue":"1","key":"3434_CR8","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.ad.2017.06.024","volume":"110","author":"F Boria","year":"2019","unstructured":"Boria F, Maseda R, Mart\u00edn-Came\u00e1n M, De la Calle M, de Lucas R. Recessive dystrophic epidermolysis bullosa and pregnancy. Actas Dermo-Sifiliogr\u00e1ficas Engl Ed. 2019;110(1):50\u20132.","journal-title":"Actas Dermo-Sifiliogr\u00e1ficas Engl Ed"},{"issue":"1","key":"3434_CR9","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1742-4755-6-18","volume":"6","author":"AP Betr\u00e1n","year":"2009","unstructured":"Betr\u00e1n AP, Gulmezoglu AM, Robson M, Merialdi M, Souza JP, Wojdyla D, et al. WHO Global Survey on Maternal and Perinatal Health in Latin America: classifying caesarean sections. Reprod Health. 2009;6(1):18.","journal-title":"Reprod Health"},{"key":"3434_CR10","unstructured":"PNDS - \u00c9pidermolyses bulleuses h\u00e9r\u00e9ditaires. 2015; https:\/\/www.has-sante.fr\/upload\/docs\/application\/pdf\/202110\/fimarad_synthese_pnds_ebh_v3_chb30092021_final.pdf"},{"issue":"4","key":"3434_CR11","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1111\/j.1365-2133.2009.09306.x","volume":"161","author":"S Tabolli","year":"2009","unstructured":"Tabolli S, Sampogna F, Di Pietro C, Paradisi A, Uras C, Zotti P, et al. Quality of life in patients with epidermolysis bullosa. Br J Dermatol. 2009;161(4):869\u201377.","journal-title":"Br J Dermatol"},{"key":"3434_CR12","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jdcr.2021.09.007","volume":"17","author":"J Dang","year":"2021","unstructured":"Dang J, McCuaig CC, Funaro D. Vulvar involvement in epidermolysis bullosa: case series. JAAD Case Rep. 2021;17:21\u20137.","journal-title":"JAAD Case Rep"},{"key":"3434_CR13","doi-asserted-by":"publisher","unstructured":"Montaudi\u00e9 H, Chiaverini C, Sbidian E, Charlesworth A, Lacour JP. Inherited epidermolysis bullosa and squamous cell carcinoma: a systematic review of 117 cases. Orphanet J Rare Dis [Internet]. 2016 [cited 2022 Aug 14];11(1). http:\/\/ojrd.biomedcentral.com\/articles\/https:\/\/doi.org\/10.1186\/s13023-016-0489-9","DOI":"10.1186\/s13023-016-0489-9"},{"key":"3434_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/242046","volume":"2014","author":"N Colgrove","year":"2014","unstructured":"Colgrove N, Elkattah R, Herrell H. Dystrophic epidermolysis bullosa in pregnancy: a case report of the autosomal dominant subtype and review of the literature. Case Rep Med. 2014;2014:1\u20135.","journal-title":"Case Rep Med"},{"issue":"1","key":"3434_CR15","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/j.1365-2230.2011.04179.x","volume":"37","author":"T Hanafusa","year":"2012","unstructured":"Hanafusa T, Tamai K, Umegaki N, Yamaguchi Y, Fukuda S, Nishikawa Y, et al. The course of pregnancy and childbirth in three mothers with recessive dystrophic epidermolysis bullosa: pregnancy and childbirth in RDEB. Clin Exp Dermatol. 2012;37(1):10\u20134.","journal-title":"Clin Exp Dermatol"},{"key":"3434_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.crwh.2019.e00140","volume":"24","author":"N Shah","year":"2019","unstructured":"Shah N, Kumaraswami S, Mushi JE. Management of epidermolysis bullosa simplex in pregnancy: a case report. Case Rep Womens Health. 2019;24: e00140.","journal-title":"Case Rep Womens Health"},{"issue":"2","key":"3434_CR17","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ijoa.2007.04.008","volume":"17","author":"MS Baloch","year":"2008","unstructured":"Baloch MS, Fitzwilliams B, Mellerio J, Lakasing L, Bewley S, O\u2019Sullivan G. Anaesthetic management of two different modes of delivery in patients with dystrophic epidermolysis bullosa. Int J Obstet Anesth. 2008;17(2):153\u20138.","journal-title":"Int J Obstet Anesth"},{"issue":"2","key":"3434_CR18","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jclinane.2013.08.008","volume":"26","author":"M Turmo-Tejera","year":"2014","unstructured":"Turmo-Tejera M, Garc\u00eda-Navia JT, Su\u00e1rez F, Echevarr\u00eda-Moreno M. Cesarean delivery in a pregnant woman with mutilating recessive dystrophic epidermolysis bullosa. J Clin Anesth. 2014;26(2):155\u20137.","journal-title":"J Clin Anesth"},{"key":"3434_CR19","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ijoa.2017.01.010","volume":"30","author":"M Ara\u00fajo","year":"2017","unstructured":"Ara\u00fajo M, Br\u00e1s R, Frada R, Guedes-Martins L, Lemos P. Caesarean delivery in a pregnant woman with epidermolysis bullosa: anaesthetic challenges. Int J Obstet Anesth. 2017;30:68\u201372.","journal-title":"Int J Obstet Anesth"},{"key":"3434_CR20","unstructured":"INSERM Enqu\u00eate nationale p\u00e9rinatale- rapport 2021.pdf. https:\/\/enp.inserm.fr\/wp-content\/uploads\/2022\/10\/rapport-2022-v5.pdf"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-024-03434-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-024-03434-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-024-03434-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T14:28:16Z","timestamp":1742567296000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-024-03434-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,21]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3434"],"URL":"https:\/\/doi.org\/10.1186\/s13023-024-03434-0","relation":{},"ISSN":["1750-1172"],"issn-type":[{"type":"electronic","value":"1750-1172"}],"subject":[],"published":{"date-parts":[[2025,3,21]]},"assertion":[{"value":"9 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki. All participants were verbally informed of the study, the study\u2019s information note was given to them; All participants gave their informed consent before their data was included in the study; these actions are also filled in each participant\u2019s medical record. This study on medical records data has been approved and registered (reference R04-049) by the Nice University Hospital Data Protection Officer in the data treatments registry under the declaration of conformity to the CNIL (the French Commission protecting the public\u2019s privacy) reference methodology MR004. This protocol was\u00a0registered at ClinicalTrials.gov (no.\u00a0NCT04757727).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The patients whose photos are published have given their written informed consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"140"}}